Last reviewed · How we verify

NCT06956638

Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation

Completed Last updated 7 May 2025
What this trial tests

trial testing Non-interventional in Acute Appendicitis in 98 participants. Completed in 12 March 2025.

Timeline
16 July 2022
Primary endpoint
15 June 2023
12 March 2025

Quick facts

Lead sponsorNepalese Army Institute of Health Sciences
StatusCompleted
Study typeOBSERVATIONAL
Enrollment98
Start date16 July 2022
Primary completion15 June 2023
Estimated completion12 March 2025
Sites1 location across Nepal

Drugs / interventions tested

Conditions studied

Sponsor

Nepalese Army Institute of Health Sciences

Who can join

5 and older, any sex, with Acute Appendicitis or Appendicitis Perforated. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to learn if serum bilirubin levels can aid in the diagnosis of acute appendicitis and predict appendiceal perforation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Non-interventional

Trials testing the same drug.

Other recruiting trials for Acute Appendicitis

Currently open trials in the same condition.

Other Nepalese Army Institute of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06956638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing